Institute of Chemistry, Biological Chemistry Laboratory, Universidade Estadual de Campinas, C.P. 6154, Campinas, SP, CEP 13083-970, Brazil.
Brazilian Nanotechnology National Laboratory (LNNano-CNPEM), Campinas, SP, Brazil.
Appl Microbiol Biotechnol. 2016 Aug;100(15):6555-6570. doi: 10.1007/s00253-016-7657-7. Epub 2016 Jun 11.
The antimicrobial impact of biogenic-synthesized silver-based nanoparticles has been the focus of increasing interest. As the antimicrobial activity of nanoparticles is highly dependent on their size and surface, the complete and adequate characterization of the nanoparticle is important. This review discusses the characterization and antimicrobial activity of biogenic synthesized silver nanoparticles and silver chloride nanoparticles. By revising the literature, there is confusion in the characterization of these two silver-based nanoparticles, which consequently affects the conclusion regarding to their antimicrobial activities. This review critically analyzes recent publications on the synthesis of biogenic silver nanoparticles and silver chloride nanoparticles by attempting to correlate the characterization of the nanoparticles with their antimicrobial activity. It was difficult to correlate the size of biogenic nanoparticles with their antimicrobial activity, since different techniques are employed for the characterization. Biogenic synthesized silver-based nanoparticles are not completely characterized, particularly the nature of capped proteins covering the nanomaterials. Moreover, the antimicrobial activity of theses nanoparticles is assayed by using different protocols and strains, which difficult the comparison among the published papers. It is important to select some bacteria as standards, by following international foundations (Pharmaceutical Microbiology Manual) and use the minimal inhibitory concentration by broth microdilution assays from Clinical and Laboratory Standards Institute, which is the most common assay used in antibiotic ones. Therefore, we conclude that to have relevant results on antimicrobial effects of biogenic silver-based nanoparticles, it is necessary to have a complete and adequate characterization of these nanostructures, followed by standard methodology in microbiology protocols.
生物合成银基纳米粒子的抗菌作用一直是人们关注的焦点。由于纳米粒子的抗菌活性高度依赖于其尺寸和表面,因此对纳米粒子进行完整和充分的表征非常重要。本文综述了生物合成银纳米粒子和氯化银纳米粒子的特性和抗菌活性。通过查阅文献,发现这两种基于银的纳米粒子的表征存在混淆,这会影响到对其抗菌活性的结论。本文通过尝试将纳米粒子的表征与其抗菌活性相关联,对近期关于生物合成银纳米粒子和氯化银纳米粒子的合成进行了批判性分析。由于采用了不同的技术对纳米粒子进行表征,因此很难将生物合成纳米粒子的大小与其抗菌活性相关联。生物合成的银基纳米粒子没有得到完全的表征,特别是覆盖纳米材料的帽状蛋白质的性质。此外,这些纳米粒子的抗菌活性是通过不同的方案和菌株进行检测的,这使得很难对已发表的论文进行比较。选择一些细菌作为标准是很重要的,遵循国际基金会(《医药微生物手册》),并使用临床和实验室标准研究所的肉汤微量稀释法测定最小抑菌浓度,这是抗生素检测中最常用的方法。因此,我们得出结论,为了获得有关生物合成银基纳米粒子抗菌效果的相关结果,有必要对这些纳米结构进行完整和充分的表征,并遵循微生物学方案中的标准方法。